A recall of infant ibuprofen has just been expanded weeks after Tris Pharma, Inc. recalled three lots of their Infants’ Ibuprofen Concentrated Oral Suspension USP (NSAID) 50 mg per 1.25 mL. The medications affected by this were sold at Walmart, CVS and Family Dollar Services stores under the brand names CVS Ibuprofen, Family Wellness Infants’ Ibuprofen and Equate Infants’ Ibuprofen.

The recall has since been expanded to include three additional lots of the medication that may be affected. The recall was issued in the first place because experts were worried that the medication had potentially higher concentrations of ibuprofen than stated on the label.

“Studies have shown that safety issues or toxicity is generally accepted to be a concern in infants at doses in excess of 700% of the recommended dose,” Tris Pharma said in a statement. “To date, no serious adverse events have been reported related to this recall.”

The medications affected by this were sold in 1/2 oz. and 1 oz. bottles at the stores listed above. Two of the medications were sold at CVS under the names Infants’ Ibuprofen Concentrated Oral Suspension, with the lot numbers 4718 and 00717006A, while a third was sold at Walmart under the name Equate: Infants’ Ibuprofen Concentrated Oral Suspension with lot number 00717005A.

Tris Pharma, Inc Expands Its Voluntary Nationwide Retail Recall of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, Due to Higher Concentration of Ibuprofen https://t.co/srOmORgXBO

— U.S. FDA (@FDArecalls) January 30, 2019

Affects of taking this medication include nausea, vomiting and pain high in the stomach right below the chest. Diarrhea, ringing in the ears, headache and gastrointestinal bleeding can also result from taking the medication.